Polio eradication vaccine investment: how do we ensure polio vaccines are available to keep the world polio-free after transmission of wild poliovirus (wPV) has been interrupted?

Batson, Amie; Federgruen, Awi; Ganguly, Nirmal Kumar; Glassman, Amanda; Makoni, Simba; Plotkin, Stanley

Batson, Amie; Federgruen, Awi; Ganguly, Nirmal Kumar; Glassman, Amanda; Makoni, Simba; Plotkin, Stanley.

Afiliación

Batson A; Global health strategist/expert; Former Chief Strategy Officer and Vice President of Applied Analytics and Learning, PATH, Seattle, Washington DC, USA aebatson@gmail.com.
Federgruen A; Chair of the Decision, Risk, and Operations (DRO) Division, Columbia University & Graduate School of Business, Columbia University, New York, New York, USA.
Ganguly NK; Honorary Senior Research Professor, Institute of Liver and Biliary Sciences, New Delhi, India.
Glassman A; Former Director General, Indian Council of Medical Research (ICMR), New Delhi, India.
Makoni S; Executive Vice President & Senior Fellow, Center for Global Development (CGD), Washington, DC, USA.
Plotkin S; Former Executive Secretary, Southern African Development Community, Gaborone, Botswana.

BMJ Glob Health ; 6(11)2021 11.

Article en En | MEDLINE | ID: mdl-34810205

Asunto(s)

Poliomielitis; Vacunas contra Poliovirus; Poliovirus; Humanos; Poliomielitis/epidemiología; Poliomielitis/prevención & control

Palabras clave

immunisation; paediatrics; poliomyelitis; public health; vaccines

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Poliomielitis / Vacunas contra Poliovirus / Poliovirus Límite: Humans Idioma: En Revista: BMJ Glob Health Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google